Pharmacological targeting of mitophagy via ALT001 improves herpes simplex virus 1 (HSV1)-mediated microglial inflammation and promotes amyloid β phagocytosis by restricting HSV1 infection
- Theranostics, 2025-3-31; 15(11):4890-4908 | doi:10.7150/thno.10595
